MedTrace Logo

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

NCT05033288 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2026-03-13

No results posted yet for this study

Summary

This study compares carbon ion therapy, surgery, and proton therapy to determine if one has better disease control and fewer side effects. There are three types of radiation treatment used for pelvic bone sarcomas: surgery with or without photon/proton therapy, proton therapy alone, and carbon ion therapy alone. The purpose of this study is to compare quality of life among patients treated for pelvic bone sarcomas across the world, and to determine if carbon ion therapy improves quality of life compared to surgery and disease control compared with proton therapy.

Conditions

  • Bone Sarcoma
  • Chondrosarcoma
  • Chordoma
  • Ewing Sarcoma of Bone
  • Pelvic Rhabdomyosarcoma

Interventions

OTHER

Electronic Health Record Review

Medical records are reviewed

OTHER

Quality-of-Life Assessment

Complete quality of life questionnaires

Sponsors & Collaborators

Principal Investigators

  • Bradford S. Hoppe, MD, MPH · Mayo Clinic

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-20
Primary Completion
2027-08-30
Completion
2031-08-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05033288 on ClinicalTrials.gov